The Regulatory Effect of PPARγ in the Apoptosis against Renal Cell Carcinoma
10.3969/j.issn.1003-4706.2018.05.007
- VernacularTitle:PPARγ在肾癌细胞凋亡中的调控作用
- Author:
Lei YE
1
;
Fa-Chun TONG
;
Jian LI
;
Long WANG
;
Jian-Ming ZHAO
;
Yi LIU
;
Jian WANG
Author Information
1. 玉溪市人民医院泌尿外科
- Keywords:
PPARγ;
T0070907;
Rosiglitazone;
Apoptosis
- From:
Journal of Kunming Medical University
2018;39(5):29-34
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effects of PPARγ agonist rosiglitazone and inhibitor T0070907 on apoptosis and anti-tumor in renal carcinoma A498 cells.Methods A498 cells were divided into three groups and PBS, rosiglitazone (50 μmol/L) and T0070907 50 (μmol/L) were added respectively of 24 h incubation completely. each group of cell proliferation was determined by MTT method and Western Blot analysis and RT-qPCR were applied to detect the expression level of BAX, Caspase 3, Cyt C and Bcl-2. A498 cell morphological changes were observed under light microscope and fluorescence microscope. Results MTT experiment results showed that rosiglitazone and T0070907 could significantly inhibit A498 cell proliferation rate (P＜0.05), increased the protein and mRNA expression levels of Caspase 3, Cyt C and Bax in A498 cell, and decreased the protein and mRNA expression levels of Bcl-2 (P＜0.05); Microscopic observation and Hochest staining also found that rosiglitazone and T0070907 could promote apoptosis of A498 cells. Conclusion Rosiglitazone and T0070907 can inhibit the proliferation of renal cell carcinoma A498 cells and induce apoptosis. The anti-tumor mechanism may be related to PPARγ mediation.
